Insight Molecular Diagnostics Inc (IMDX)

NASDAQ

$4.84

OncoCyte Corporation is a precision diagnostics company in the United States and internationally. The company is headquartered in Irvine, California.

Sector:

Industry:

68 analysts

Buy

Target: $8.33 (+72.11%)

Market Cap

$156M

Free Cash Flow Yield

-17.64%

Beta (5Y)

0.79

Adjust inflation

Log

Valuation

Market Cap$156M

P/S79.86

P/B87.06

Profitability

Total Revenue (TTM)$1.95M

Gross Profit (TTM)$995K

EBITDA-$46M

Operating Margin-32275%

EPS-$1.65

Financial Health

Free Cash Flow Yield-17.64%

Growth & Risk

EPS 5Y CAGR-25.97%

Revenue 5Y CAGR-3.46%

FCF 5Y CAGR-2.39%

Beta (5Y)0.79

Sharpe Ratio1.00